SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-13-023123
Filing Date
2013-04-22
Accepted
2013-04-22 15:30:10
Documents
8
Period of Report
2013-04-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v341958_8-k.htm 8-K 17123
2 EXHIBIT 4.1 v341958_ex4-1.htm EX-4.1 83364
3 EXHIBIT 5.1 v341958_ex5-1.htm EX-5.1 8535
4 EXHIBIT 10.1 v341958_ex10-1.htm EX-10.1 194142
5 EXHIBIT 10.2 v341958_ex10-2.htm EX-10.2 79867
6 EXHIBIT 99.1 v341958_ex99-1.htm EX-99.1 7713
7 GRAPHIC header.jpg GRAPHIC 8374
8 GRAPHIC footer.jpg GRAPHIC 13622
  Complete submission text file 0001144204-13-023123.txt   422463
Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

IRS No.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35737 | Film No.: 13773729
SIC: 2834 Pharmaceutical Preparations